Literature DB >> 26177932

Interactions between glutamate, dopamine, and the neuronal signature of response inhibition in the human striatum.

Robert C Lorenz1,2,3, Tobias Gleich1,4, Ralph Buchert5, Florian Schlagenhauf1,6, Simone Kühn7,8, Jürgen Gallinat1,8.   

Abstract

Response inhibition is a basic mechanism in cognitive control and dysfunctional in major psychiatric disorders. The neuronal mechanisms are in part driven by dopamine in the striatum. Animal data suggest a regulatory role of glutamate on the level of the striatum. We used a trimodal imaging procedure of the human striatum including F18-DOPA positron emission tomography, proton magnetic resonance spectroscopy, and functional magnetic resonance imaging of a stop signal task. We investigated dopamine synthesis capacity and glutamate concentration in vivo and their relation to functional properties of response inhibition. A mediation analysis revealed a significant positive association between dopamine synthesis capacity and inhibition-related neural activity in the caudate nucleus. This relationship was significantly mediated by striatal glutamate concentration. Furthermore, stop signal reaction time was inversely related to striatal activity during inhibition. The data show, for the first time in humans, an interaction between dopamine, glutamate, and the neural signature of response inhibition in the striatum. This finding stresses the importance of the dopamine-glutamate interaction for behavior and may facilitate the understanding of psychiatric disorders characterized by impaired response inhibition.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  dopamine; functional magnetic resonance imaging; glutamate; magnetic resonance spectroscopy; multimodal imaging; positron emission tomography; response inhibition; striatum

Mesh:

Substances:

Year:  2015        PMID: 26177932      PMCID: PMC6869374          DOI: 10.1002/hbm.22895

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  54 in total

Review 1.  Modeling intracellular signaling underlying striatal function in health and disease.

Authors:  Anu G Nair; Omar Gutierrez-Arenas; Olivia Eriksson; Alexandra Jauhiainen; Kim T Blackwell; Jeanette H Kotaleski
Journal:  Prog Mol Biol Transl Sci       Date:  2014       Impact factor: 3.622

2.  Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach.

Authors:  A Breier; C M Adler; N Weisenfeld; T P Su; I Elman; L Picken; A K Malhotra; D Pickar
Journal:  Synapse       Date:  1998-06       Impact factor: 2.562

3.  Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.

Authors:  Andreas Meyer-Lindenberg; Robert S Miletich; Philip D Kohn; Giuseppe Esposito; Richard E Carson; Mario Quarantelli; Daniel R Weinberger; Karen Faith Berman
Journal:  Nat Neurosci       Date:  2002-03       Impact factor: 24.884

4.  Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis.

Authors:  Camilo de la Fuente-Sandoval; Pablo León-Ortiz; Rafael Favila; Sylvana Stephano; David Mamo; Jesús Ramírez-Bermúdez; Ariel Graff-Guerrero
Journal:  Neuropsychopharmacology       Date:  2011-04-20       Impact factor: 7.853

5.  Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

Authors:  F X Vollenweider; P Vontobel; I Oye; D Hell; K L Leenders
Journal:  J Psychiatr Res       Date:  2000 Jan-Feb       Impact factor: 4.791

Review 6.  Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis.

Authors:  James M Swanson; Marcel Kinsbourne; Joel Nigg; Bruce Lanphear; Gerry A Stefanatos; Nora Volkow; Eric Taylor; B J Casey; F Xavier Castellanos; Pathik D Wadhwa
Journal:  Neuropsychol Rev       Date:  2007-03       Impact factor: 7.444

7.  Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET.

Authors:  Shoko Nozaki; Motoichiro Kato; Harumasa Takano; Hiroshi Ito; Hidehiko Takahashi; Ryosuke Arakawa; Masaki Okumura; Yota Fujimura; Ryohei Matsumoto; Miho Ota; Akihiro Takano; Akihiko Otsuka; Fumihiko Yasuno; Yoshiro Okubo; Haruo Kashima; Tetsuya Suhara
Journal:  Schizophr Res       Date:  2008-12-04       Impact factor: 4.939

8.  Relationship of striatal dopamine synthesis capacity to age and cognition.

Authors:  Meredith N Braskie; Claire E Wilcox; Susan M Landau; James P O'Neil; Suzanne L Baker; Cindee M Madison; Jennifer T Kluth; William J Jagust
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

9.  Age-dependent decline of steady state dopamine storage capacity of human brain: an FDOPA PET study.

Authors:  Yoshitaka Kumakura; Ingo Vernaleken; Hans-Georg Buchholz; Per Borghammer; Erik Danielsen; Gerhard Gründer; Andreas Heinz; Peter Bartenstein; Paul Cumming
Journal:  Neurobiol Aging       Date:  2008-06-09       Impact factor: 4.673

Review 10.  Insights into the neural basis of response inhibition from cognitive and clinical neuroscience.

Authors:  Christopher D Chambers; Hugh Garavan; Mark A Bellgrove
Journal:  Neurosci Biobehav Rev       Date:  2008-09-11       Impact factor: 8.989

View more
  13 in total

1.  Glutaminergic signaling in the caudate nucleus is required for behavioral sensitization to methylphenidate.

Authors:  Nicholas King; Samuel Floren; Natasha Kharas; Ming Thomas; Nachum Dafny
Journal:  Pharmacol Biochem Behav       Date:  2019-06-19       Impact factor: 3.533

2.  Nicotine-induced activation of caudate and anterior cingulate cortex in response to errors in schizophrenia.

Authors:  Lauren V Moran; Luke E Stoeckel; Kristina Wang; Carolyn E Caine; Rosemond Villafuerte; Vanessa Calderon; Justin T Baker; Dost Ongur; Amy C Janes; A Eden Evins; Diego A Pizzagalli
Journal:  Psychopharmacology (Berl)       Date:  2017-11-27       Impact factor: 4.530

3.  Co-Variation of Peripheral Levels of miR-1202 and Brain Activity and Connectivity During Antidepressant Treatment.

Authors:  Juan Pablo Lopez; Fabricio Pereira; Stéphane Richard-Devantoy; Marcelo Berlim; Eduardo Chachamovich; Laura M Fiori; Paola Niola; Gustavo Turecki; Fabrice Jollant
Journal:  Neuropsychopharmacology       Date:  2017-01-12       Impact factor: 7.853

4.  The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR study.

Authors:  Antoine Rogeau; Giovanna Nordio; Mattia Veronese; Kirsten Brown; Matthew M Nour; Martin Osugo; Sameer Jauhar; Oliver D Howes; Robert A McCutcheon
Journal:  Mol Psychiatry       Date:  2022-05-11       Impact factor: 15.992

Review 5.  Transcranial Direct Current Stimulation as an Approach to Mitigate Neurodevelopmental Disorders Affecting Excitation/Inhibition Balance: Focus on Autism Spectrum Disorder, Schizophrenia, and Attention Deficit/Hyperactivity Disorder.

Authors:  Beatriz Sousa; João Martins; Miguel Castelo-Branco; Joana Gonçalves
Journal:  J Clin Med       Date:  2022-05-18       Impact factor: 4.964

Review 6.  Schizophrenia: synthetic strategies and recent advances in drug design.

Authors:  Maria Azmanova; Anaïs Pitto-Barry; Nicolas P E Barry
Journal:  Medchemcomm       Date:  2018-03-16       Impact factor: 3.597

7.  Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.

Authors:  Zheng Ye; Charlotte L Rae; Cristina Nombela; Timothy Ham; Timothy Rittman; Peter Simon Jones; Patricia Vázquez Rodríguez; Ian Coyle-Gilchrist; Ralf Regenthal; Ellemarije Altena; Charlotte R Housden; Helen Maxwell; Barbara J Sahakian; Roger A Barker; Trevor W Robbins; James B Rowe
Journal:  Hum Brain Mapp       Date:  2016-01-12       Impact factor: 5.038

8.  Glutamatergic and GABAergic gene sets in attention-deficit/hyperactivity disorder: association to overlapping traits in ADHD and autism.

Authors:  J Naaijen; J Bralten; G Poelmans; J C Glennon; B Franke; J K Buitelaar
Journal:  Transl Psychiatry       Date:  2017-01-10       Impact factor: 6.222

9.  GABA, Glutamate and Neural Activity: A Systematic Review With Meta-Analysis of Multimodal 1H-MRS-fMRI Studies.

Authors:  Amanda Kiemes; Cathy Davies; Matthew J Kempton; Paulina B Lukow; Carly Bennallick; James M Stone; Gemma Modinos
Journal:  Front Psychiatry       Date:  2021-03-08       Impact factor: 4.157

10.  Dysfunction in superior frontal gyrus associated with diphasic dyskinesia in Parkinson's disease.

Authors:  Yu-Ting Shen; Yong-Sheng Yuan; Min Wang; Yan Zhi; Jian-Wei Wang; Li-Na Wang; Ke-Wei Ma; Qian-Qian Si; Ke-Zhong Zhang
Journal:  NPJ Parkinsons Dis       Date:  2020-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.